1,2-dipalmitoylphosphatidylcholine has been researched along with moxifloxacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, J; Hayes, D; Li, X; Mansour, HM; Vogt, FG | 1 |
| Cavallaro, A; Das, SC; Doyle, C; Eedara, BB; Rangnekar, B | 1 |
2 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and moxifloxacin
| Article | Year |
|---|---|
Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Anti-Bacterial Agents; Aza Compounds; Desiccation; Drug Carriers; Drug Compounding; Drug Design; Fluoroquinolones; Gases; Moxifloxacin; Nanoparticles; Ofloxacin; Particle Size; Powders; Quinolines; Solutions | 2013 |
The influence of surface active l-leucine and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co-spray dried powders.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Aerosols; Antitubercular Agents; Chemistry, Pharmaceutical; Desiccation; Excipients; Fluoroquinolones; Leucine; Moxifloxacin; Particle Size; Powders; Pyrazinamide | 2018 |